A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor ' s Choice for Advanced Breast Cancer

Conditions: Advanced Breast Cancer Interventions: Drug: apatinib mesylate+Capecitabine Tablets; Drug: apatinib mesylate+Fulvestrant injection Sponsors: Li Huiping Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials